Docetaxel in Node Positive Adjuvant Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: 5-fluorouracil|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Sanofi
Collaborators: Cancer International Research Group (CIRG)